Acquired Immunodeficiency Syndrome
📧 Sign up to get email alerts when something new happens for Acquired Immunodeficiency Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Longitudinal Study of Ocular Complications of AIDS (LSOCA)
This entry notes that the Longitudinal Study of Ocular Complications of AIDS (LSOCA) sponsored by Johns Hopkins has completed.
-
FDA approval · 2015-06-08FDA Approved: MEGESTROL ACETATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for Megestrol Acetate (generic megestrol acetate) under ANDA 203139.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Atorvastatin for HAART Suboptimal Responders [Phase 3]
Phase 3 trial evaluating atorvastatin for HIV patients on HAART who are suboptimal responders; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Pilot Study of Immediate HIV Treatment in Guangxi, China [NA]
This document provides an update on a pilot clinical trial in Guangxi, China evaluating immediate HIV treatment initiation. The trial status…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan) [Phase 2]
Phase 2 study results report safety and immunogenicity of an AIDS vaccine using a DNA vaccine in combination with recombinant vaccinia Tiant…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Risk of CV Events With EFV vs. EFV-free Regimens
This completed clinical trial compares the risk of cardiovascular events in people treated with efavirenz-containing regimens versus EFV-fre…
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Antidepressant Treatment of AIDS Related Depression. [Phase 2]
This update reports the completion of a Phase 2 trial evaluating an antidepressant for AIDS-related depression.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes [Phase 4]
This Phase 4 trial evaluates the pharmacokinetics of antituberculosis drugs and tuberculosis treatment outcomes. The current status is unkno…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Kaiser Permanente HIV Cohort Study
This entry notes the completion of the Kaiser Permanente HIV Cohort Study (NCT01339403) with results posted in 2015. The provided snippet do…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Enhanced HIV Prevention in Couples: Feasibility Study #1
This is a completed feasibility study update on enhanced HIV prevention in couples (NCT02027714).
-
CLINICAL_TRIALS research · 2015-03-19Clinical Trial Update: HIV Medication Adherence in Underserved Populations [NA]
An update on a clinical trial addressing HIV medication adherence in underserved populations, with the trial status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). [Phase 1]
This is a completed Phase I trial evaluating Peptide T for neuropsychiatric complications of HIV/AIDS. The update notes preliminary efficacy…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients [Phase 3]
Phase 3 trial evaluating switching virologically suppressed HIV-1 patients from a ritonavir-boosted protease inhibitor plus emtricitabine/te…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients [Phase 3]
Phase 3 trial evaluating switching virologically suppressed HIV-1-infected patients from regimens containing an NNRTI plus Emtricitabine and…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients [Phase 3]
Phase 3 open-label pilot evaluating switching virologically suppressed HIV-1 patients from raltegravir plus emtricitabine/tenofovir DF to th…
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV [NA]
The University of Washington–sponsored clinical trial evaluated strategies to improve uptake of early infant diagnosis of HIV to prevent mot…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision [NA]
This Clinical Trial Update reports completion of a study evaluating text messaging to improve adherence to clinic visits and reduce early re…
-
FDA approval · 2014-12-23FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Multi-level Determinants of Starting ART Late: Aim 3
This completed clinical trial update summarizes Aim 3 of a study examining multilevel determinants of starting antiretroviral therapy late i…
-
CLINICAL_TRIALS research · 2014-12-16Clinical Trial Update: Multi-level Determinants of Starting ART Late: Aim 2
This entry reports on the Columbia University–sponsored study 'Multi-level Determinants of Starting ART Late: Aim 2', examining factors asso…
-
EMA trial_result · 2014-11-28New antiretrovirals improve quality of life of HIV/AIDS patients
The EMA report highlights new antiretroviral therapies that improve quality of life for people living with HIV/AIDS, indicating positive pat…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
This Clinical Trial Update summarizes a completed study assessing the acceptability, effectiveness, and cost of mobile phone technology to p…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients [Phase 4]
A Phase 4 trial evaluated omega-3 fatty acids for high triglycerides in HIV-infected patients; the study has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment [Phase 3]
Phase 3 results for cobicistat-containing highly active antiretroviral regimens in HIV-1 infected patients with mild to moderate renal impai…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults [Phase 3]
Phase 3 trial evaluating safety and efficacy of cobicistat-boosted darunavir in HIV-infected adults has completed with results posted in 201…